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Editors: Anton N. Sidawy and Bruce A. PerlerAnalysis of risk factors for abdominal aortic aneurysm in a cohort of more
than 3 million individuals
K. Craig Kent, Robert M. Zwolak, Natalia N. Egorova, Thomas S. Riles,
Andrew Manganaro, Alan J. Moskowitz, Annetine C. Gelijns, Giampaolo
Greco
Background: Abdominal aortic aneurysm (AAA) disease is an insidious condi-
tion with an 85% chance of death after rupture. Ultrasound screening can
reduce mortality, but its use is advocated only for a limited subset of the
population at risk.
Methods: We used data from a retrospective cohort of 3.1 million patients
who completed a medical and lifestyle questionnaire and were evaluated
by ultrasound imaging for the presence of AAA by Life Line Screening in
2003 to 2008. Risk factors associated with AAA were identified using multi-
variable logistic regression analysis.
Results: We observed a positive association with increasing years of smoking
and cigarettes smoked and a negative association with smoking cessation.
Excess weight was associated with increased risk, whereas exercise and
consumption of nuts, vegetables, and fruits were associated with reduced
risk. Blacks, Hispanics, and Asians had lower risk of AAA than whites and
Native Americans. Well-known risk factors were reaffirmed, including male
gender, age, family history, and cardiovascular disease. A predictive scoring
system was created that identifies aneurysms more efficiently than current
criteria and includes women, nonsmokers, and individuals aged <65 years.
Using this model on national statistics of risk factors prevalence, we esti-
mated 1.1 million AAAs in the United States, of which 569,000 are among
women, nonsmokers, and individuals aged <65 years.
Conclusions: Smoking cessation and a healthy lifestyle are associated with
lower risk of AAA. We estimated that about half of the patients with AAA
disease are not eligible for screening under current guidelines. We have
created a high-yield screening algorithm that expands the target population
for screening by including at-risk individuals not identified with existing
screening criteria.Risk factors for late mortality after endovascular repair of the thoracic
aorta
Jayer Chung, Matthew A. Corriere, Ravi K. Veeraswamy, Karthikeshwar
Kasirajan, Ross Milner, Thomas F. Dodson, Atef A. Salam, Elliot L. Chaikof
Objective: This study was conducted to identify risk factors for late
mortality after thoracic endovascular aortic repair (TEVAR).
Methods: A retrospective analysis of consecutive TEVAR was conducted.
Medical record review, telephone contact, or query of the Social Security
Death Index was used to determine 30-day and late survival. Late mortality
was assessed with respect to patient characteristics at the time of the initial
treatment, preoperative laboratory values, pathology, clinical presentation,* Full articles available online at www.jvascsurg.org
1078e5884/$36.00
doi:10.1016/S1078-5884(10)00476-4and treatment adjuncts. Significant univariate predictors of death were
entered into a multivariate Cox proportional hazards model.
Results: From 1998 to 2009, 252 patients (149 men; mean age, 68 years)
underwent TEVAR for degenerative thoracic aortic aneurysm (TAA,
n = 143), type B dissection (n = 62), mycotic aneurysm (n = 13), traumatic
disruption (n = 12), penetrating ulcer or intramural hematoma (n = 10), anas-
tomotic pseudoaneurysm (n = 4), or other pathology (n = 8). The 30-day
mortality was 9.5%, with stroke or spinal cord injury in 5.6%. Mean follow-
up was 22  22 months. Kaplan-Meier mean survival was 53 months. Predic-
tors of late mortality by univariate analysis included age (P < .01), cardiac
arrhythmia (P = .03), chronic obstructive pulmonary disease (P = .05),
aneurysm diameter (P < .01), rupture (P < .01), debranching (P = .02), leuko-
cytosis (white blood cell count > 10.0  103/mL; P < .01), albumin, (P < .01),
and creatinine > 1.7 mg/dL (P = .01). Multivariate predictors of mortality
included rupture (hazard ratio [HR], 3.10; 95% confidence interval [CI],
1.02-9.44; P = .03), debranching (HR, 2.20; 95% CI, 1.09-4.24; P = .03),
preoperative leukocytosis (HR, 1.23; 95% CI, 1.09-1.39; P = .001), and
aneurysm diameter (HR, 1.02; 95% CI, 1.01-1.03; P = .04). Subgroup analysis
of patients undergoing TEVAR for asymptomatic, nonruptured TAA demon-
strated that debranching (HR, 2.47; 95% CI, 1.13-5.39; P = .02), White blood
cell count (HR, 1.19; 95% CI, 1.01-1.40; P < .04), and aneurysm diameter
(HR, 1.03; 95% CI, 1.01-1.05, P < .01) remain independently predictive of
late mortality.
Conclusions: Preoperative leukocytosis, aneurysm diameter, and concur-
rent debranching independently predict late mortality irrespective of
clinical presentation and may assist in risk stratification.Four-year randomized prospective comparison of percutaneous ePTFE/
nitinol self-expanding stent graft versus prosthetic femoral-popliteal
bypass in the treatment of superficial femoral artery occlusive disease
Karen McQuade, Dennis Gable, Greg Pearl, Brian Theune, Steve Black
Background: This is a randomized prospective study comparing the treat-
ment of superficial femoral artery occlusive disease percutaneously with
an expanded polytetrafluoroethylene (ePTFE)/nitinol self-expanding stent
graft (stent graft) versus surgical femoral to above-knee popliteal artery
bypass with synthetic graft material.
Methods: One hundred limbs in 86 patients with superficial femoral artery
occlusive disease were evaluated from March 2004 to May 2005. Patient
symptoms included both claudication and limb threatening ischemia with
or without tissue loss. Trans-Atlantic InterSociety Consensus (TASC II) A (n
= 18), B (n = 56), C (n = 11), and D (n = 15) lesions were included. Patients
were randomized prospectively into one of two treatment groups; a percuta-
neous treatment group (group A; n = 50) with angioplasty and placement of
one or more stent grafts, or a surgical treatment group (group B; n = 50) with
a femoral to above-knee popliteal artery bypass using synthetic conduit
(Dacron or ePTFE). Patients were followed for 48 months. Follow-up evalu-
ation included clinical assessment, physical examination, ankle-brachial
indices, and color flow duplex sonography at 3, 6, 9, 12, 18, 24, 36, and
48 months.
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graft group was 25.6 cm (SD = 15 cm). The stent graft group demonstrated
a primary patency of 72%, 63%, 63%, and 59% with a secondary patency of
83%, 74%, 74%, and 74% at 12, 24, 36, and 48 months, respectively. The
surgical femoral-popliteal group demonstrated a primary patency of 76%,
63%, 63%, and 58% with a secondary patency of 86%, 76%, 76%, and 71% at
12, 24, 36, and 48 months, respectively. No statistical difference was found
between the two groups with respect to primary (P = .807) or secondary
(P = .891) patency.
Conclusion: Management of superficial femoral artery occlusive disease
with percutaneous stent grafts exhibits similar primary patency at 4-year
(48 month) follow up when compared with conventional femoral-popliteal
artery bypass grafting with synthetic conduit. This treatment method may
offer an alternative to treatment of the superficial femoral artery segment
for revascularization when prosthetic bypass is being considered or when
autologous conduit is unavailable.Histologic atherosclerotic plaque characteristics are associated with
restenosis rates after endarterectomy of the common and superficial
femoral arteries
Wouter J.M. Derksen, Jean-Paul P.M. de Vries, Aryan Vink, Evelyn Velema,
Jan-Albert Vos, Dominique de Kleijn, Frans L. Moll, Gerard Pasterkamp
Objectives: This study assessed the predictive value of histologic plaque
characteristics for the occurrence of restenosis after femoral artery
endarterectomy.
Background: It would be advantageous if patients at increased risk for
restenosis after arterial endarterectomy could be identified by histologic
characteristics of the dissected plaque. Differences in atherosclerotic pla-
que composition of the carotid artery have been associated with restenosis
rates after surgical endarterectomy. However, whether atherosclerotic
plaque characteristics are also predictive for restenosis in other vascular
territories is unknown.
Methods: Atherosclerotic plaques of 217 patients who underwent a common
femoral artery endarterectomy (CFAE; n = 124) or remote superficial femoral
artery endarterectomy (RSFAE; n = 93) were examined and scored micro-
scopically for the presence of collagen, macrophages, smooth muscle cells,
lipid core, intraplaque hemorrhage, and calcifications. The 12-month reste-
nosis rate was assessed using duplex ultrasound imaging (peak systolic
velocity [PSV] ratio 2.5).
Results: The 1-year restenosis rate was 66% (61 of 93) after RSFAE compared
to 21% (26 of 124) after CFAE. Plaque with characteristics of high collagen
and smooth muscle cell content were positively associated with the occur-
rence of restenosis, with odds ratios (ORs) of 2.90 (95% confidence interval
[CI], 1.82-4.68) and 2.20 (1.50-3.20) for superficial femoral artery (SFA)
and common femoral artery (CFA), respectively. SFA plaques showed signif-
icantly heavier staining for collagen (69% vs 31% for CFA; P < .001) and
smooth muscle cells (64% vs 36% for CFA; P < .001). After multivariate anal-
ysis, the operation type (CFAE or RSFAE), gender, and the presence of
collagen were independent predictive variables for restenosis after endar-
terectomy of the CFA and SFA.
Conclusion: Plaque composition of the CFA and SFA differs. Furthermore,
the dissection of a fibrous collagen-rich plaque is an independent predictive
variable for restenosis after endarterectomy of the CFA and SFA.Leg strength predicts mortality in men but not in women with peripheral
arterial disease
Nimarta Singh, Kiang Liu, Lu Tian, Michael H. Criqui, Jack M. Guralnik, Luigi
Ferrucci, Yihua Liao, Mary M. McDermott
Objective: To establish associations between leg strength and mortality in
men and women with lower extremity peripheral arterial disease (PAD).
Methods: This was an observational, prospective study of 410 men and
women with PAD aged 55 and older recruited from Chicago-area medical
centers and followed for a mean of 60 months. The participants were fol-
lowed for a mean of 60.0 months. Isometric knee extension, knee flexion,
hip extension, and hip flexion were measured at baseline. Primary outcomes
were all-cause and cardiovascular disease mortality. Cox proportional
hazards models were used to assess relations between leg strength andall-cause and cardiovascular disease mortality among men and women, ad-
justing for age, race, comorbidities, physical activity, smoking, body mass
index, and the ankle brachial index.
Results: Among the 246 male participants, poorer baseline strength for knee
flexion (P trend = .029), knee extension (P trend =.010), and hip extension (P
trend = .013) were each associated independently with higher all-cause
mortality. Poorer strength for knee flexion (P trend = .042) and hip extension
(P trend = .029) were associated with higher cardiovascular mortality.
Compared with those in the fourth (best) baseline knee flexion quartile,
hazard ratios for all-cause and cardiovascular disease mortality among
men in the first (poorest) knee flexion quartile were 2.23 (95% confidence
interval [CI], 1.02-4.87; P = .045) and 4.20 (95% CI, 1.12-15.79; P = .044),
respectively. No significant associations of leg strength and all-cause
mortality were identified among women.
Conclusions: Poorer leg strength is associated with increased mortality in
men, but not women, with PAD. Future study is needed to determine
whether interventions that increase leg strength improve survival in men
with PAD.Younger women with symptomatic peripheral arterial disease are at
increased risk of depressive symptoms
Kim G. Smolderen, John A. Spertus, Patrick W. Vriens, Steef Kranendonk,
Maria Nooren, Johan Denollet
Objectives: Gender disparities, particularly among young women with
cardiovascular disease, are a growing cause for concern. Depression is a prev-
alent and prognostically important comorbidity in peripheral arterial disease
(PAD), but its prevalence has not been described as a function of gender and
age. Therefore, we compared depressive symptoms at the time of PAD diag-
nosis and 6 months later by gender and age in PAD patients.
Methods: The study enrolled 444 newly diagnosed patients with PAD (32%
women) from two Dutch vascular outpatient clinics. Patients’ depressive
symptoms were assessed with the 10-item Center for Epidemiological
Studies Depression Scale (CES-D) at baseline and 6 months later (CES-D
scores 4 indicate significant depressive symptoms). Logistic regression
models were constructed to evaluate the relationship among four gender-
age groups (women <65 and 65 years; men <65 and 65 years [reference
category]) and baseline and 6-month follow-up depressive symptoms.
Results: Initially, 33% of women <65 years had significant depressive symp-
toms, and 6 months later, significant depressive symptoms had developed in
19% of the other younger women. These rates were much higher than other
gender-age groups (range at baseline, 11%-16%; 6-month incidence, 6%-10%;
P  .03). Adjusting for demographics and clinical factors, women <65 years
experienced a fourfold greater odds of baseline (odds ratio [OR], 4.3; 95%
confidence interval [CI], 2.2-8.7) and follow-up depressive symptoms (OR,
4.1; 95% CI, 2.0-8.4) compared with men 65 years, whereas other
gender-age groups were not at risk. Additional adjustment for change in
the ankle-brachial index did not explain the increased depression risk in
younger women (OR, 3.5; 95% CI, 1.2-10.2).
Conclusions: Significant depressive symptoms are more common in younger
women with PAD than in other gender-age groups, both at the time of diag-
nosis and 6 months later. To eradicate gender-based disparities in PAD,
depression screening and monitoring in younger women may be an important
direction for future research and intervention.A randomized, controlled trial of endovenous thermal ablation using the
810-nm wavelength laser and the ClosurePLUS radiofrequency ablation
methods for superficial venous insufficiency of the great saphenous vein
Steven S. Gale, Jennifer N. Lee, M. Eileen Walsh, Dennis L. Wojnarowski,
Anthony J. Comerota
Background: Great saphenous vein (GSV) incompetence is the most common
cause of superficial venous insufficiency. Radiofrequency catheter ablation
(RFA) is superior to conventional ligation and stripping, and endovenous laser
treatment (EVL) has emerged as an effective alternative to RFA. This
randomized study evaluated RFA and EVL for superficial venous insufficiency
due to GSV incompetence and compared early and 1-year results.
Methods: Between June 2006 and May 2008, patients with symptomatic
primary venous insufficiency due to GSV incompetence were randomized
418 Abstractsto RFA or EVL. Patients with bilateral disease were randomized for treat-
ment of the first leg and received the alternative method on the other.
Pretreatment examination included a leg assessment using the Venous
Clinical Severity Score (VCSS) and CEAP classification. Patients completed
the Chronic Venous Insufficiency Questionnaire 2 (CIVIQ2). RFA was per-
formed with the ClosurePlus system (VNUS Medical Technologies, Sunnyvale,
Calif). EVL was performed with the EVLT system (AngioDynamics Inc,
Queensbury, NY). Early (1-week and 1-month) postoperative results of pain,
bruising, erythema, and hematoma were recorded. Duplex ultrasound (DU)
imaging was used at 1 week and 1 year to evaluate vein status. VCSS scores
and CEAP clinical class were recorded at each postoperative visit, and
quality of life (QOL) using CIVIQ2 was assessed at 1 month and 1 year.
Results: The study enrolled 118 patients (141 limbs): 46 (39%) were random-
ized to RFA and 48 (40%) to EVL, and 24 (20%) had bilateral GSV incompe-
tence. At 1 week, one patient in the RFA group had an open GSV and was
deemed a failure. More bruising occurred in the EVL group (P = .01) at 1
week, but at 1 month, there was no difference in bruising between groups.
At 1 year, DU imaging showed evidence of recanalization with reflux in 11
RFA and 2 EVL patients (P = .002). The mean VCSS score change from
baseline to 1 week postprocedure was higher for RFA than EVL (P = .002),
but there was no difference between groups at 1 month (P = .07) and 1 year
(P = .9). Overall QOL mean score improved over time for all patients
(P < .001). CEAP clinical class scores of 3 were recorded in 21 RFA (44%)
and 24 EVL patients (44%) pretreatment, but at 1-year, 9 RFA (19%) and 12
EVL patients (24%) had scores of 3 (P < .001). This represented a significant
improvement in all patients compared with baseline.
Conclusion: Both methods of endovenous ablation effectively reduce symp-
toms of superficial venous insufficiency. EVL is associated with greater
bruising and discomfort in the perioperative period but may provide a more
secure closure over the long-term than RFA.The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI)
predicts cardiac complications more accurately than the Revised
Cardiac Risk Index in vascular surgery patients
Daniel J. Bertges, Philip P. Goodney, Yuanyuan Zhao, Andres Schanzer, Brian
W. Nolan, Donald S. Likosky, Jens Eldrup-Jorgensen, Jack L. Cronenwett,
for the Vascular Study Group of New England
Objective: The Revised Cardiac Risk Index (RCRI) is a widely used model for
predicting cardiac events after noncardiac surgery. We compared the accu-
racy of the RCRI with a new, vascular surgery-specific model developed from
patients within the Vascular Study Group of New England (VSGNE).Methods: We studied 10,081 patients who underwent nonemergent carotid
endarterectomy (CEA; n = 5293), lower extremity bypass (LEB; n = 2673),
endovascular abdominal aortic aneurysm repair (EVAR; n = 1005), and open
infrarenal abdominal aortic aneurysm repair (OAAA; n = 1,110) within the
VSGNE from 2003 to 2008. First, we analyzed the ability of the RCRI to
predict in-hospital major adverse cardiac events, including myocardial
infarction (MI), arrhythmia, or congestive heart failure (CHF) in the VSGNE
cohort. Second, we used a derivation cohort of 8208 to develop a new
cardiac risk prediction model specifically for vascular surgery patients.
Chi-square analysis identified univariate predictors, and multivariate logistic
regression was used to develop an aggregate and four procedure-specific risk
prediction models for cardiac complications. Calibration and model discrim-
ination were assessed using Pearson correlation coefficient and receiver
operating characteristic (ROC) curves. The ability of the model to predict
cardiac complications was assessed within a validation cohort of 1873.
Significant predictors were converted to an integer score to create a prac-
tical cardiac risk prediction formula.
Results: The overall incidence of major cardiac events in the VSGNE cohort
was 6.3% (2.5% MI, 3.9% arrhythmia, 1.8% CHF). The RCRI predicted risk after
CEA reasonably well but substantially underestimated risk after LEB, EVAR,
and OAAA for low- and higher-risk patients. Across all VSGNE patients, the
RCRI underestimated cardiac complications by 1.7- to 7.4-fold based on
actual event rates of 2.6%, 6.7%, 11.6%, and 18.4% for patients with 0, 1,
2, and 3 risk factors. In multivariate analysis of the VSGNE cohort, indepen-
dent predictors of adverse cardiac events were (odds ratio [OR]) increasing
age (1.7-2.8), smoking (1.3), insulin-dependent diabetes (1.4), coronary
artery disease (1.4), CHF (1.9), abnormal cardiac stress test (1.2), long-term
b-blocker therapy (1.4), chronic obstructive pulmonary disease (1.6), and
creatinine 1.8 mg/dL (1.7). Prior cardiac revascularization was protective
(OR, 0.8). Our aggregate model was well calibrated (r = 0.99, P < .001),
demonstrating moderate discriminative ability (ROC curve = 0.71), which
differed only slightly from the procedure-specific models (ROC curves:
CEA, 0.74; LEB, 0.72; EVAR, 0.74; OAAA, 0.68). Rates of cardiac complica-
tions for patients with 0 to 3, 4, 5, and 6 VSG risk factors were 3.1%,
5.0%, 6.8%, and 11.6% in the derivation cohort and 3.8%, 5.2%, 8.1%, and
10.1% in the validation cohort. The VSGNE cardiac risk model more accu-
rately predicted the actual risk of cardiac complications across the four
procedures for low- and higher-risk patients than the RCRI. When the VSG
Cardiac Risk Index (VSG-CRI) was used to score patients, six categories of risk
ranging from 2.6% to 14.3% (score of 0-3 to 8) were discernible.
Conclusions: The RCRI substantially underestimates in-hospital cardiac
events in patients undergoing elective or urgent vascular surgery, especially
after LEB, EVAR, and OAAA. The VSG-CRI more accurately predicts in-
hospital cardiac events after vascular surgery and represents an important
tool for clinical decision making.
